Intragenic PTEN/MMAC1 loss of heterozygosity in conventional (clear-cell) renal cell carcinoma is associated with poor patient prognosis (Q74099329)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12011252%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

title

Intragenic PTEN/MMAC1 loss of heterozygosity in conventional (clear-cell) renal cell carcinoma is associated with poor patient prognosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12011252%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

1 reference

2

Brett Delahunt

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12011252%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

author name string

Marija Velickovic

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12011252%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Bryan McIver

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12011252%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Stefan K G Grebe

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12011252%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

publication date

1 May 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12011252%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12011252%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12011252%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12011252%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

479-485

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12011252%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/modpathol.3880551

8 November 2019

exact match

0 references

cites work

The Heidelberg classification of renal cell tumours.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880551

7 January 2021

Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC)

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880551

7 January 2021

Histopathology and molecular genetics of renal tumors toward unification of a classification system

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880551

7 January 2021

Development of papillary renal cell tumours is associated with loss of Y-chromosome-specific DNA sequences

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880551

7 January 2021

Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880551

7 January 2021

Mitochondrial and chromosomal DNA alterations in human chromophobe renal cell carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880551

7 January 2021

Low chromosome number in chromophobe renal cell carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880551

7 January 2021

Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880551

7 January 2021

Infrequent genetic alterations of the PTEN/MMAC1 gene in Japanese patients with primary cancers of the breast, lung, pancreas, kidney, and ovary

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880551

7 January 2021

Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880551

7 January 2021

PTEN/MMAC1/TEP1 mutations in human primary renal-cell carcinomas and renal carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880551

7 January 2021

Allelic loss at 10q23.3 but lack of mutation of PTEN/MMAC1 in chromophobe renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880551

7 January 2021

Prognostic significance of morphologic parameters in renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880551

7 January 2021

Convenient single-step, one tube purification of PCR products for direct sequencing

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880551

7 January 2021

Dideoxy fingerprinting (ddF): A rapid and efficient screen for the presence of mutations

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880551

7 January 2021

Allelic loss of chromosome 10q23 is associated with tumor progression in breast carcinomas.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880551

7 January 2021

Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880551

7 January 2021

PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanismsin haematological malignancies

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880551

7 January 2021

Pten is essential for embryonic development and tumour suppression

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880551

7 January 2021

Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880551

7 January 2021